Risk Factors for Delta Hepatitis in a North American Cohort: Who Should Be Screened?

  • Ben L. Da
  • , Farial Rahman
  • , Walter C. Lai
  • , David E. Kleiner
  • , Theo Heller
  • , Christopher Koh

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Abstract

INTRODUCTION:The American Association for the Study of Liver Diseases recommends hepatitis D virus (HDV) screening in certain high-risk groups; however, the effectiveness is unknown.METHODS:A study of North American patients with hepatitis B (HBV) referred to the NIH was performed to identify risk factors associated with HDV infection. Active HDV was "confirmed" by serum HDV RNA or histologic HDV antigen staining.RESULTS:Six hundred fifty-two were studied, of which 91 were HDV "confirmed." Independent risk factors for HDV included: intravenous drug users, HBV-DNA <2,000 IU/mL, alanine aminotransferase >40 U/L, and HDV endemic country of origin.DISUSSION:North American patients with HBV and significant risk factors should be screened for HDV.

Original languageEnglish
Pages (from-to)206-209
Number of pages4
JournalAmerican Journal of Gastroenterology
Volume116
Issue number1
DOIs
StatePublished - 1 Jan 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Risk Factors for Delta Hepatitis in a North American Cohort: Who Should Be Screened?'. Together they form a unique fingerprint.

Cite this